239 related articles for article (PubMed ID: 19914814)
1. Effect of mannitol and repetitive coughing on the sputum properties in bronchiectasis.
Daviskas E; Anderson SD; Young IH
Respir Med; 2010 Mar; 104(3):371-7. PubMed ID: 19914814
[TBL] [Abstract][Full Text] [Related]
2. Inhaled mannitol for the treatment of mucociliary dysfunction in patients with bronchiectasis: effect on lung function, health status and sputum.
Daviskas E; Anderson SD; Gomes K; Briffa P; Cochrane B; Chan HK; Young IH; Rubin BK
Respirology; 2005 Jan; 10(1):46-56. PubMed ID: 15691238
[TBL] [Abstract][Full Text] [Related]
3. Beneficial effect of inhaled mannitol and cough in asthmatics with mucociliary dysfunction.
Daviskas E; Anderson SD; Eberl S; Young IH
Respir Med; 2010 Nov; 104(11):1645-53. PubMed ID: 20576419
[TBL] [Abstract][Full Text] [Related]
4. Inhalation of dry powder mannitol improves clearance of mucus in patients with bronchiectasis.
Daviskas E; Anderson SD; Eberl S; Chan HK; Bautovich G
Am J Respir Crit Care Med; 1999 Jun; 159(6):1843-8. PubMed ID: 10351929
[TBL] [Abstract][Full Text] [Related]
5. Effect of inhaled dry powder mannitol on mucus and its clearance.
Daviskas E; Rubin BK
Expert Rev Respir Med; 2013 Feb; 7(1):65-75. PubMed ID: 23362816
[TBL] [Abstract][Full Text] [Related]
6. Inhaled mannitol changes the sputum properties in asthmatics with mucus hypersecretion.
Daviskas E; Anderson SD; Young IH
Respirology; 2007 Sep; 12(5):683-91. PubMed ID: 17875056
[TBL] [Abstract][Full Text] [Related]
7. Effect of increasing doses of mannitol on mucus clearance in patients with bronchiectasis.
Daviskas E; Anderson SD; Eberl S; Young IH
Eur Respir J; 2008 Apr; 31(4):765-72. PubMed ID: 18057051
[TBL] [Abstract][Full Text] [Related]
8. Inhaled mannitol for non-cystic fibrosis bronchiectasis: a randomised, controlled trial.
Bilton D; Tino G; Barker AF; Chambers DC; De Soyza A; Dupont LJ; O'Dochartaigh C; van Haren EH; Vidal LO; Welte T; Fox HG; Wu J; Charlton B;
Thorax; 2014 Dec; 69(12):1073-9. PubMed ID: 25246664
[TBL] [Abstract][Full Text] [Related]
9. Mucoactive agents for chronic, non-cystic fibrosis lung disease: A systematic review and meta-analysis.
Tarrant BJ; Le Maitre C; Romero L; Steward R; Button BM; Thompson BR; Holland AE
Respirology; 2017 Aug; 22(6):1084-1092. PubMed ID: 28397992
[TBL] [Abstract][Full Text] [Related]
10. Relationship between bronchial reversibility and tracheobronchial clearance in patients with chronic bronchitis.
Moretti M; Lopez-Vidriero MT; Pavia D; Clarke SW
Thorax; 1997 Feb; 52(2):176-80. PubMed ID: 9059481
[TBL] [Abstract][Full Text] [Related]
11. Inhaled mannitol improves the hydration and surface properties of sputum in patients with cystic fibrosis.
Daviskas E; Anderson SD; Jaques A; Charlton B
Chest; 2010 Apr; 137(4):861-8. PubMed ID: 19880909
[TBL] [Abstract][Full Text] [Related]
12. Regional lung clearance during cough and forced expiration technique (FET): effects of flow and viscoelasticity.
Hasani A; Pavia D; Agnew JE; Clarke SW
Thorax; 1994 Jun; 49(6):557-61. PubMed ID: 8016793
[TBL] [Abstract][Full Text] [Related]
13. Inhaled mannitol in the treatment of non-cystic fibrosis bronchiectasis in adults.
Gjoerup J; Hilberg O; Bendstrup E
Respirology; 2012 Aug; 17(6):927-32. PubMed ID: 22564014
[TBL] [Abstract][Full Text] [Related]
14. Effects of an Airway Clearance Device on Inflammation, Bacteriology, and Mucus Transport in Bronchiectasis.
Tambascio J; de Souza HCD; Martinez R; Baddini-Martinez JA; Barnes PJ; Gastaldi AC
Respir Care; 2017 Aug; 62(8):1067-1074. PubMed ID: 28733314
[TBL] [Abstract][Full Text] [Related]
15. Pharmacologic agents for mucus clearance in bronchiectasis.
Nair GB; Ilowite JS
Clin Chest Med; 2012 Jun; 33(2):363-70. PubMed ID: 22640851
[TBL] [Abstract][Full Text] [Related]
16. Impaired tracheobronchial clearance in bronchiectasis.
Currie DC; Pavia D; Agnew JE; Lopez-Vidriero MT; Diamond PD; Cole PJ; Clarke SW
Thorax; 1987 Feb; 42(2):126-30. PubMed ID: 3433236
[TBL] [Abstract][Full Text] [Related]
17. The 24-h effect of mannitol on the clearance of mucus in patients with bronchiectasis.
Daviskas E; Anderson SD; Eberl S; Chan HK; Young IH
Chest; 2001 Feb; 119(2):414-21. PubMed ID: 11171717
[TBL] [Abstract][Full Text] [Related]
18. The effect of inhaled mannitol on bronchial mucus clearance in cystic fibrosis patients: a pilot study.
Robinson M; Daviskas E; Eberl S; Baker J; Chan HK; Anderson SD; Bye PT
Eur Respir J; 1999 Sep; 14(3):678-85. PubMed ID: 10543292
[TBL] [Abstract][Full Text] [Related]
19. Osmotic stimuli increase clearance of mucus in patients with mucociliary dysfunction.
Daviskas E; Robinson M; Anderson SD; Bye PT
J Aerosol Med; 2002; 15(3):331-41. PubMed ID: 12396422
[TBL] [Abstract][Full Text] [Related]
20. Short-term recombinant human DNase in bronchiectasis. Effect on clinical state and in vitro sputum transportability.
Wills PJ; Wodehouse T; Corkery K; Mallon K; Wilson R; Cole PJ
Am J Respir Crit Care Med; 1996 Aug; 154(2 Pt 1):413-7. PubMed ID: 8756815
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
